HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Srdan Verstovsek Selected Research

Transaminases (Aminotransferases)

1/2020Long-term results of a phase 2 trial of nilotinib 400 mg twice daily in newly diagnosed patients with chronic-phase chronic myeloid leukemia.
12/2015Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
10/2008Clofarabine combinations as acute myeloid leukemia salvage therapy.
1/2008Phase I study of alternate-week administration of tipifarnib in patients with myelodysplastic syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Srdan Verstovsek Research Topics

Disease

202Primary Myelofibrosis (Myelosclerosis)
04/2024 - 05/2006
119Neoplasms (Cancer)
02/2024 - 05/2003
62BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2021 - 03/2002
60Polycythemia Vera
02/2024 - 06/2006
58Splenomegaly
06/2023 - 10/2004
53Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 11/2002
51Anemia
04/2024 - 05/2005
36Myelodysplastic Syndromes (Myelodysplastic Syndrome)
10/2020 - 07/2002
33Essential Thrombocythemia
01/2024 - 01/2003
33Philadelphia Chromosome
07/2020 - 05/2002
31Leukemia
01/2021 - 05/2002
29Thrombocytopenia (Thrombopenia)
04/2024 - 05/2006
25Cytopenia
06/2023 - 05/2006
23Hematologic Neoplasms (Hematological Malignancy)
01/2020 - 12/2003
21Systemic Mastocytosis
07/2022 - 10/2006
20Fibrosis (Cirrhosis)
11/2023 - 10/2009
14Blast Crisis (Blast Phase)
01/2021 - 01/2006
13Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2020 - 10/2003
12Fatigue
11/2023 - 01/2003
11Acute Promyelocytic Leukemia
01/2022 - 05/2003
10Myeloproliferative Disorders (Myeloproliferative Disorder)
09/2013 - 09/2003
9Thrombosis (Thrombus)
07/2023 - 05/2008
9Disease Progression
06/2023 - 05/2002
8Hypereosinophilic Syndrome (Loeffler Endocarditis)
01/2022 - 08/2005
8Inflammation (Inflammations)
04/2021 - 07/2014
8Leukocytosis (Pleocytosis)
01/2019 - 12/2003
8Infections
09/2018 - 03/2003
7Polycythemia (Erythrocytosis)
02/2024 - 08/2007
7Pathologic Complete Response
07/2020 - 01/2003
7Multiple Myeloma
01/2018 - 05/2003
7Thrombocytosis (Thrombocythemia)
02/2017 - 09/2003
6Diarrhea
10/2023 - 01/2008
6Hemorrhage
11/2022 - 12/2015
6B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2022 - 04/2003
5Myeloid Leukemia (Leukemia, Myelocytic)
01/2021 - 05/2003
5Sepsis (Septicemia)
07/2020 - 11/2004
5Lymphoma (Lymphomas)
01/2019 - 04/2006
4Pneumonia (Pneumonitis)
09/2023 - 01/2006
4Neutropenia
01/2023 - 06/2003
4Exanthema (Rash)
01/2020 - 01/2008

Drug/Important Bio-Agent (IBA)

132ruxolitinibIBA
02/2024 - 01/2009
56Janus Kinase InhibitorsIBA
02/2024 - 01/2009
42Imatinib Mesylate (Gleevec)FDA Link
01/2020 - 05/2002
41Janus KinasesIBA
11/2023 - 02/2008
25N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamideIBA
02/2024 - 01/2017
24Janus Kinase 2IBA
05/2021 - 11/2005
22Tyrosine Kinase InhibitorsIBA
11/2021 - 09/2003
20CytokinesIBA
01/2024 - 01/2009
20Cytarabine (Cytosar-U)FDA LinkGeneric
01/2021 - 05/2002
19InterferonsIBA
01/2024 - 06/2003
19Hydroxyurea (Hydrea)FDA LinkGeneric
07/2023 - 06/2006
18Phosphotransferases (Kinase)IBA
01/2022 - 03/2006
1711- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA
04/2024 - 01/2015
16Janus Kinase 1IBA
11/2023 - 01/2013
16Proteins (Proteins, Gene)FDA Link
11/2022 - 03/2002
15Hemoglobins (Hemoglobin)IBA
11/2023 - 05/2005
13fedratinibIBA
04/2023 - 01/2019
13Telomerase (Telomerase Reverse Transcriptase)IBA
12/2022 - 03/2003
13Interferon-alpha (Interferon Alfa)IBA
10/2016 - 01/2003
10Lenalidomide (CC 5013)FDA Link
01/2018 - 08/2006
9Reticulin (Reticular Fiber)IBA
01/2022 - 10/2009
9Arsenic Trioxide (Trisenox)FDA Link
01/2017 - 05/2003
8DecitabineFDA Link
01/2021 - 06/2005
8Dasatinib (BMS 354825)FDA Link
11/2020 - 06/2008
7IronIBA
01/2023 - 07/2006
7Alemtuzumab (Campath)FDA Link
01/2022 - 05/2003
7ArsenicIBA
04/2016 - 05/2003
7Prednisone (Sone)FDA LinkGeneric
01/2016 - 09/2009
6Danazol (Azol)FDA LinkGeneric
11/2023 - 12/2016
6Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
11/2021 - 05/2002
6Clofarabine (Clolar)FDA Link
01/2021 - 10/2003
6Gemtuzumab (Mylotarg)FDA Link
01/2017 - 03/2003
6Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
01/2017 - 05/2003
6Rituximab (Mabthera)FDA Link
11/2015 - 04/2003
5HepcidinsIBA
02/2024 - 01/2020
5Biomarkers (Surrogate Marker)IBA
02/2024 - 06/2022
5activin AIBA
11/2023 - 01/2023
5navitoclaxIBA
12/2022 - 01/2022
5imetelstatIBA
12/2022 - 01/2017
5Histone Deacetylase InhibitorsIBA
10/2022 - 11/2006
5CladribineFDA LinkGeneric
01/2021 - 08/2005
5fludarabineIBA
01/2020 - 03/2003
5nilotinibFDA Link
01/2020 - 07/2005
5Monoclonal AntibodiesIBA
01/2019 - 09/2004
5Thalidomide (Thalomid)FDA Link
01/2018 - 05/2006
5pomalidomideIBA
10/2017 - 09/2009
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2003 - 03/2002
4Syntex adjuvant formulationIBA
02/2024 - 08/2016
4Activin Receptors (Activin Receptor)IBA
10/2023 - 12/2016
4LigandsIBA
12/2022 - 12/2016
4Messenger RNA (mRNA)IBA
01/2022 - 05/2002
4avapritinibIBA
12/2021 - 01/2018
4ErythropoietinFDA Link
01/2021 - 06/2008

Therapy/Procedure

210Therapeutics
02/2024 - 01/2003
24Drug Therapy (Chemotherapy)
01/2022 - 03/2003
10Drug Tapering
10/2023 - 06/2003
10Stem Cell Transplantation
01/2021 - 03/2003
7Induction Chemotherapy
01/2017 - 11/2004
6Immunotherapy
01/2021 - 03/2007
5Cell Transplantation
01/2023 - 01/2016